Synapse - Works

Results (2146)

Response to letter to the editor, Gilks et al

Correspondence

Weigelt, B.; Mueller, J. J.; Ellenson, L. H.; Abu-Rustum, N. R.; Aghajanian, C.
Gynecologic Oncology (2023)

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator's choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy

Meeting Abstract

Lacuna, K. P.; Mandrekar, S. J.; Allred, J. B.; Berg, S. A.; Hensley, M. L.; Van Tine, B. A.; George, S.; Schwartz, G. K.; Ingham, M.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma

Meeting Abstract

Vergote, I.; Mirza, M. R.; Coleman, R. L.; Perez-Fidalgo, J. A.; Monk, B. J.; Valabrega, G.; Slomovitz, B. M.; Van Gorp, T.; Moore, K. N.; Sehouli, J.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

CRI-CCTG-0003/IND.240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC)

Meeting Abstract

Mackay, H.; Tinker, A.; Nelson, B.; Zamarin, D.; Odunsi, K.; Lheureux, S.; Ellard, S.; Smrke, A.; Gaudreau, P. O.; Faulkner, T.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

UPGRADE-A: Phase 1 expansion trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi) in combination with carboplatin in patients with high-grade serous ovarian cancer (HGSOC)

Meeting Abstract

Hays, J. L.; Friedman, C. F.; Lakhani, N.; Anderson, C. K.; Buscema, J.; Duska, L. R.; Hamilton, E. P.; Taylor, S. E.; Carrington, C.; Burger, R. A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

First-in-human phase 1/2 study of ubamatamab, a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer

Meeting Abstract

Moore, K. N.; Bouberhan, S.; Hamilton, E. P.; Liu, J. F.; O'Cearbhaill, R. E.; O'Malley, D. M.; Papadamitriou, K.; Schröder, D.; Van N., Els; Yoo, S. Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma

Meeting Abstract

Chiang, S.; Hensley, M. L.; Vasudevaraja, V.; Tran, I.; Yang, Y.; Stewart, C. J. R.; Park, K. J.; Ellenson, L. H.; Sikkink, K.; Schmitt, A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Integrating technology to support data management abstraction of adverse events (AE) and concomitant medications (ConMed) from the electronic health record (EHR) to sponsor electronic data capture (EDC) systems using design thinking (DT) methodology

Meeting Abstract

Yuravlivker, L.; Buckley, M. T.; Bouvier, N.; Jeevarathnam, S.; Lazan, S.; Panchal, R.; McKellop, M.; Lengfellner, J. M.; Terzulli, S. L.; Sabbatini, P.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Long-term follow up of selinexor maintenance in patients with TP53 wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study

Meeting Abstract

Slomovitz, B. M.; Perez-Fidalgo, J. A.; Hamilton, E. P.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Klat, J.; Levy, T.; Welch, S.; Richardson, D. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Falls and hospitalization during chemotherapy in older women with early breast cancer

Meeting Abstract

Ji, J.; Sun, C. L.; Wildes, T. M.; Freedman, R. A.; Magnuson, A.; O'Connor, T.; Moy, B.; Klepin, H. D.; Chapman, A. E.; Tew, W. P.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save